Skip to content
Riskpilot
← Back to search
Sign in
Get full access
CarryGenes Therapeutics AB
AB
Active
Org 5591464689
Rörstrandsgatan 58, 113 40
Stockholm
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2018
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
CarryGenes Therapeutics AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-0M
-1M
-1M
-1M
-5M
2020
-2M
2021
-1M
2022
-2M
2023
-1M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−5 211
−1 773
−1 396
−1 787
−555
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−5 211
−1 773
−1 396
−1 787
−555
Net financials
—
—
—
16
−87 648
Profit before tax
−5 212
−1 773
−1 396
−1 771
−44 433
Tax
2 929
376
302
390
−3 997
Net profit
−2 283
−1 397
−1 094
−1 381
−48 430
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
162 723
160 733
160 169
162 002
135 077
Equity
161 865
160 468
159 375
157 993
131 518
Long-term debt
0
0
0
685
0
Short-term debt
858
265
794
3 323
3 560
Total debt
858
265
794
4 008
3 560
Financial ratios
5-year trend
EBITDA margin
-55500000.0%
This company
15.8%
Market median
-351265923% vs market
2020
2024
Equity ratio
97.4%
This company
38.2%
Market median
+155% vs market
2020
2024
Return on equity
-36.8%
This company
18.4%
Market median
-300% vs market
2020
2024
Net profit margin
-4843000000.0%
This company
8.1%
Market median
-59790123557% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on CarryGenes Therapeutics AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
